Infant Bacterial Therapeutics
Anthon Jahreskog is on the Board of Directors at Infant Bacterial Therapeutics. Anthon is the former Chief Operating Officer, Fund Linked Products at Credit Suisse Investment Bank in London.
Anthon is currently working as a business strategist and advisor in various industries. He's also a member of the Board of Directors of BioGaia AB (publ) and of Fast Track Holdings Ltd.
Anthon earned an MSc in Financial Management from the University of Cape Town in 2006.
This person is not in the org chart
This person is not in any offices
Infant Bacterial Therapeutics
IBT is a clinical stage pharmaceutical company with a vision to develop drugs influencing the infant microbiome, and thereby prevent or treat rare diseases affecting infants.